Conference item icon

Conference item

Methodological mimesis and the value of pharmaceutical failures

Abstract:

Recent controversies over the safety of drugs such as Vioxx, a painkiller manufactured by Merck, and Seroxat, an SSRI antidepressant manufactured by GlaxoSmithKline, have led to a consequence that at first seems entirely positive: they have attracted more attention to the suppression of negative clinical trial data by industry and academic researchers, helping to establish clinical trial registries where randomized controlled trials (RCTs) must be registered at their outset. In this paper, th...

Expand abstract

Actions


Access Document


Files:

Authors


Linsey McGoey More by this author
Publication date:
2009-02-22
URN:
uuid:bcf19cc3-ff62-4cda-ad13-3c9e38da4eb8
Local pid:
oai:eureka.sbs.ox.ac.uk:380

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP